BPI
ORKA icon

BFC Planning, Inc.’s Oruka Therapeutics ORKA Stock Holding History

BFC Planning, Inc.’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43K Hold
15
– – ﹤0.01% 3065
2026
Q1 		$736 Hold
15
– – ﹤0.01% 2796
2025
Q4 		$455 Hold
15
– – ﹤0.01% 2944
2025
Q3 		$288 Hold
15
– – ﹤0.01% 2799
2025
Q2 		$168 Hold
15
– – ﹤0.01% 2611
2025
Q1 		$154 Hold
15
– – ﹤0.01% 2593
2024
Q4 		$291 Buy
+15
New +$366 ﹤0.01% 2512

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Fairmount Funds Management
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BFC Planning, Inc.'s ORKA Position: Q2 2026 in Review

BFC Planning, Inc. held its Oruka Therapeutics (ORKA) position steady in Q2 2026 at 15 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

BFC Planning, Inc. first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • BFC Planning, Inc. held 15 shares of Oruka Therapeutics worth $1.43K as of Q2 2026.
  • BFC Planning, Inc. left its Oruka Therapeutics share count unchanged in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3065 holding.
  • BFC Planning, Inc. first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.